Moreover, NFL, a newly introduced parameter serving as a marker for neuroaxonal damage and correlating with disease activity, was not found to be increased in the CSF of MS patients at the time of diagnosis, regardless of comorbid AID or isolated ABF. The gene discussed is NEFL; the disease is myeloid sarcoma.